INTRODUCTION AND OBJECTIVES: Chagas disease is the most common cause of myocarditis in Latin America, including Venezuela. Some 25% of patients progress to chronic chagasic cardiomyopathy, which is characterized by heart failure and arrhythmias. The serum levels of C-reactive protein (CRP) and interleukin-6 (IL-6) have prognostic value in non-chagasic cardiopathy. The goal of this study was to investigate the relationship between the serum levels of CRP and IL-6 and the developmental stage of Chagas disease. PATIENTS AND METHOD: The study included 64 Chagas disease patients (34 female and 30 male; age 62.2 [1.7] years) and 20 healthy individuals (10 of each sex; age 50.4 [2.7] years). Clinical investigations included echocardiography and measurement of CRP and IL-6 serum levels using ELISAs. Chagas disease patients were graded according to Carrasco et al 1994 classification. Patients with ischemic cardiopathy, liver disease, autoimmune disease, a systemic inflammatory condition, immunosuppression, cancer, pericarditis, or endocarditis were excluded. RESULTS: Multiple regression analysis demonstrated an association between Chagas disease developmental stage and the serum IL-6 level. The serum CRP level increased during only the most advanced phase of the disease. In addition, a high left ventricular mass index was associated with a high IL-6 level and male sex. CONCLUSIONS: IL-6 and CRP serum levels could be of prognostic value in assessing Chagas disease progression because there are significant correlations between elevated levels and the deterioration of cardiac function.
INTRODUCTION AND OBJECTIVES:Chagas disease is the most common cause of myocarditis in Latin America, including Venezuela. Some 25% of patients progress to chronic chagasic cardiomyopathy, which is characterized by heart failure and arrhythmias. The serum levels of C-reactive protein (CRP) and interleukin-6 (IL-6) have prognostic value in non-chagasic cardiopathy. The goal of this study was to investigate the relationship between the serum levels of CRP and IL-6 and the developmental stage of Chagas disease. PATIENTS AND METHOD: The study included 64 Chagas diseasepatients (34 female and 30 male; age 62.2 [1.7] years) and 20 healthy individuals (10 of each sex; age 50.4 [2.7] years). Clinical investigations included echocardiography and measurement of CRP and IL-6 serum levels using ELISAs. Chagas diseasepatients were graded according to Carrasco et al 1994 classification. Patients with ischemic cardiopathy, liver disease, autoimmune disease, a systemic inflammatory condition, immunosuppression, cancer, pericarditis, or endocarditis were excluded. RESULTS: Multiple regression analysis demonstrated an association between Chagas disease developmental stage and the serum IL-6 level. The serum CRP level increased during only the most advanced phase of the disease. In addition, a high left ventricular mass index was associated with a high IL-6 level and male sex. CONCLUSIONS:IL-6 and CRP serum levels could be of prognostic value in assessing Chagas disease progression because there are significant correlations between elevated levels and the deterioration of cardiac function.
Authors: Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz Journal: Cardiol Rev Date: 2012 Mar-Apr Impact factor: 2.644
Authors: José A Roldão; Marcela Beghini; Luciana S Ramalho; Carla Souza Porto; Denise B R Rodrigues; Vicente P A Teixeira; Sanívia A de Lima Pereira Journal: Parasitol Res Date: 2012-03-13 Impact factor: 2.289
Authors: Joost H van den Berg; Raquel Gomez-Eerland; Bart van de Wiel; Lenie Hulshoff; Daan van den Broek; Adriaan Bins; Hanno L Tan; Jane V Harper; Namir J Hassan; Bent K Jakobsen; Annelies Jorritsma; Christian U Blank; Ton N M Schumacher; John B A G Haanen Journal: Mol Ther Date: 2015-04-21 Impact factor: 11.454
Authors: Eliziária C Santos; Rômulo D Novaes; Marli C Cupertino; Daniel S S Bastos; Raphael C Klein; Eduardo A M Silva; Juliana L R Fietto; André Talvani; Maria T Bahia; Leandro L Oliveira Journal: Antimicrob Agents Chemother Date: 2015-07-13 Impact factor: 5.191
Authors: Cristina Poveda; Manuel Fresno; Núria Gironès; Olindo A Martins-Filho; Juan David Ramírez; Julien Santi-Rocca; José A Marin-Neto; Carlos A Morillo; Fernando Rosas; Felipe Guhl Journal: PLoS One Date: 2014-03-07 Impact factor: 3.240
Authors: Iván Darío Bravo-Tobar; Carlota Nello-Pérez; Alí Fernández; Nora Mogollón; Mary Carmen Pérez; Juan Verde; Juan Luis Concepción; Claudina Rodriguez-Bonfante; Rafael Bonfante-Cabarcas Journal: Rev Inst Med Trop Sao Paulo Date: 2015 Sep-Oct Impact factor: 1.846